Mangal Medi-Centre Profile
Key Indicators
- Paid Up Capital ₹ 0.39 M
as on 02-07-2024
- Company Age 21 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.42 Cr
as on 02-07-2024
- Satisfied Charges ₹ 9.59 M
as on 02-07-2024
- Revenue -32.21%
(FY 2021)
- Profit -32.54%
(FY 2021)
- Ebitda -32.24%
(FY 2021)
- Net Worth 3.88%
(FY 2021)
- Total Assets -1.84%
(FY 2021)
About Mangal Medi-Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.39 M.
The company currently has active open charges totaling ₹9.42 Cr. The company has closed loans amounting to ₹9.59 M, as per Ministry of Corporate Affairs (MCA) records.
Nakul Chandak and Satyanarayan Chandak serve as directors at the Company.
- CIN/LLPIN
U85110MH2003NPL139370
- Company No.
139370
- Company Classification
Private Not For Profit Company
- Incorporation Date
27 Feb 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mangal Medi-Centre?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nakul Chandak | Director | 27-Feb-2003 | Current |
Satyanarayan Chandak | Director | 27-Feb-2003 | Current |
Financial Performance of Mangal Medi-Centre.
Mangal Medi-Centre, for the financial year ended 2021, experienced significant reduction in revenue, with a 32.21% decrease. The company also saw a substantial fall in profitability, with a 32.54% decrease in profit. The company's net worth moved up by a moderate rise of 3.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Mangal Medi-Centre?
Unlock access to Mangal Medi-Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Shubhkamna Gharkul LlpActive 2 years 5 months
Nakul Chandak and Satyanarayan Chandak are mutual person
- Satyam Mats LimitedActive 26 years 6 months
Nakul Chandak and Satyanarayan Chandak are mutual person
- Mangal Life Care Private LimitedActive 10 years 6 months
Nakul Chandak and Satyanarayan Chandak are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 24 Sep 2014 | ₹6.84 Cr | Open |
Hdfc Bank Ltd. Creation Date: 10 Nov 2005 | ₹1.08 Cr | Open |
Central Bank Of India Creation Date: 07 Mar 2003 | ₹1.50 Cr | Open |
How Many Employees Work at Mangal Medi-Centre?
Unlock and access historical data on people associated with Mangal Medi-Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mangal Medi-Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mangal Medi-Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.